人类饮食衍生的多化合物和肝病:从治疗机制到临床利用
Qichao Hu1,2, Wenwen Zhang1, Feng Wei3
1State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
饮食中的多在治疗纤维化和NAFLD/NASH等肝脏疾病方面表现有前途,通过减少炎症和脂质积累. 需要进一步的研究来证实它们对肝脏健康的治疗益处.
科学领域:
- 营养科学 营养科学
- 肝病学 肝病学是一种肝病学.
- 分子生物学分子生物学
背景情况:
- 肝脏疾病在全球范围内带来了重大的健康挑战.
- 饮食干预正在越来越多地探索治疗益处.
- 来自食品中的多化合物在治疗肝脏疾病方面具有潜力.
研究的目的:
- 审查饮食中聚醇对各种肝脏疾病的改善作用.
- 阐明多在肝脏健康中的作用背后的分子机制.
- 要总结最近的进展和临床应用的多在肝脏疾病管理.
主要方法:
- 关于饮食中的多和肝脏疾病的研究文献综述.
- 分析聚所向的分子通路 (例如TGF-β,NF-κB,AMPK,Akt).
- 检查临床试验数据和支持聚醇疗效的营养证据.
主要成果:
- 聚醇通过特定的信号通路在肝损伤中表现出抗炎和抗氧化作用.
- 它们抑制肝星细胞活化,逆转肝纤维化.
- 通过抑制脂质积累来证明对NAFLD/NASH的有效性.
- 通过抑制增殖和转移,观察到抗肝细胞癌 (HCC) 活性.
结论:
- 饮食中的多醇在各种肝病中具有治疗潜力,包括损伤,纤维化,NAFLD/NASH和HCC.
- 分子机制涉及关键炎症,纤维化,代谢和瘤性途径的调节.
- 临床证据表明有好处,但进一步的研究和试验对于验证疗效至关重要.
更多相关视频
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
12:00Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro
Published on: July 5, 2017
相关概念视频
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hepatic Drug Excretion: Influencing Factors
Hepatic Drug Excretion: Enterohepatic Cycling
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
